Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy

Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy

Hepatocellular cancer is the sixth most frequently diagnosed malignant disease worldwide, and was responsible for tens of millions of deaths in 2020; however, treatment options for patients with advanced hepatocellular carcinoma remain limited. Immunotherapy has undergone rapid development over rece...

Full description

Bibliographic Details
Main Authors: Yuqing He, Mengyao Lu, Jing Che, Qian Chu, Peng Zhang, Yuan Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
biomarkers
immune checkpoint inhibitors
immune-related adverse events
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.716844/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.716844/full

Similar Items